Funding fuels expansion of the country’s most established developmental therapy model. Series C round led by aMoon Fund, B Capital and Flare Capital Partners with participation from Healthworx, ...

Laboratory assessments — from preclinical research through post-marketing surveillance — determine whether a cell-based therapy for cancer succeeds or fails. “Every developer out there advancing CAR T ...